Profil
Taylor Boyd is Chief Business Officer at Avalo Therapeutics, Inc. since 2025.
Former roles include Chief Business Officer & Executive VP at Abzena Ltd. and Investor Relations Contact at Oxford Biomedica Plc from 2022 to 2024.
Education includes graduate studies at Wake Forest University and undergraduate studies at North Carolina State University.
Postes actifs de Taylor Boyd
| Sociétés | Poste | Début |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2025 |
Anciens postes connus de Taylor Boyd
| Sociétés | Poste | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Public Communications Contact | 01/01/2024 |
| ABZENA PLC | Corporate Officer/Principal | - |
Formation de Taylor Boyd
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Abzena Ltd.
Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
















